Zafirlukast

Overview

4.7 out of 5 (9 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Jan 2023

Last Review Date

17 Aug 2023

Expiration Date

31 Dec 2025

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Zafirlukast belongs to the leukotriene receptor antagonist (LTRA) class of medications and is utilized for managing and treating chronic asthma. The medication is available in 10 mg and 20 mg chewable tablets approved by the U.S. Food and Drug Administration (FDA) for use in adults and children 5 or older. Zafirlukast is also used as an off-label medication to manage chronic urticaria, prevent exercise-induced bronchospasm, and treat allergic rhinitis. As per the Global Initiative for Asthma (GINA) guidelines, LTRA, including montelukast or zafirlukast, is an essential controller therapy for patients who cannot tolerate inhaled corticosteroids (ICS). This activity reviews the mechanism of action, adverse event profile, indications, effects, contraindications, and other crucial factors relevant to utilizing zafirlukast as an agent in managing and prophylaxis of chronic asthma.


UAN: JA4008195-9999-23-2030-H04-P

Target Audience

This activity has been designed to meet the educational needs of pharmacists.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate candidates for zafirlukast therapy, including patients with chronic asthma or those in need of adjunctive treatment, where inhaled corticosteroids are not well-tolerated.
  • Screen patients for contraindications to zafirlukast, such as hypersensitivity reactions, hepatic impairment, and concurrent medications, which may impact the safe and effective use of the drug.
  • Assess the effectiveness of zafirlukast therapy in managing asthma symptoms and improving lung function, monitoring treatment response, and adjusting the treatment plan as necessary.
  • Collaborate with other healthcare professionals, such as respiratory therapists, pharmacists, and other healthcare providers, to ensure coordinated care and optimize zafirlukast therapy, including monitoring for adverse effects and interactions.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. None of the planners of this educational activity have any relevant financial relationships to disclose.

COMMERCIAL SUPPORT: This activity has received NO commercial support.

Continuing Education Accreditation Information

Credit provided by Continuing Education, Inc, and StatPearls, LLC.

In support of improving patient care, this activity has been jointly planned and implemented by Continuing Education, Inc./University at Sea® and StatPearls, LLC. Continuing Education, Inc, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is designated for 1.00 contact hours for pharmacists.

FL Board of Pharmacy Tripartite, approval #20-608156.

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content in the activity.
  4. Choose the best answer to each activity test question. To receive credit, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment.
  6. Obtain a certificate.

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Disclaimer

Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.

  • StatPearlsand and Continuing Education, Inc, reserve the right to cancel any course due to unforeseen circumstances. StatPearls and Continuing Education, Inc, will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Medium or Media Used:

  • Computer Requirements: Internet Access
  • E-mail Address

Equal Opportunity

  • StatPearls and Continuing Education are Equal Opportunity/Affirmative Action/Equal Access Institutions. 

 

 
 

Reviews

Marquita M. on 9/6/2021

Yvanne B. on 11/11/2021

DIMITRIOS T. on 1/11/2022

Meredith K. on 4/12/2022

Abhinav P. on 12/9/2022

Meredith K. on 2/9/2023

Dariush O. on 3/2/2023

Sheila F. on 3/14/2023

Whittney H. on 8/7/2023

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 3469 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 4234.5 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user